JAGSONPAL PHARMACEUTICALS
Back to Cashflow Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-8.91 Cr | ₹-0.46 Cr | ₹-18 Cr | ₹-6.83 Cr | ₹-1.82 Cr |
What is the latest Cash Flow from Financing Activities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-8.91 Cr |
Mar2023 | ₹-0.46 Cr |
Mar2022 | ₹-18 Cr |
Mar2021 | ₹-6.83 Cr |
Mar2020 | ₹-1.82 Cr |
How is Cash Flow from Financing Activities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-8.91 Cr | Negative | |
Mar2023 | ₹-0.46 Cr | Negative | |
Mar2022 | ₹-18 Cr | Negative | |
Mar2021 | ₹-6.83 Cr | Negative | |
Mar2020 | ₹-1.82 Cr | - |
Compare Cash Flow from Financing Activities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,736.4 Cr | 9.7% | -7.4% | 66.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,661.0 Cr | -1.8% | 2.7% | 49.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,496.0 Cr | -0.2% | -3.4% | 57% | Stock Analytics | |
CIPLA | ₹121,970.0 Cr | -0.7% | 0.6% | 22.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,877.0 Cr | -1.8% | 11.3% | 18% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,163.2 Cr | 1.9% | 0.5% | 41.9% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | 9.7% |
-7.4% |
66.4% |
SENSEX | 0.7% |
-2% |
9.7% |
You may also like the below Video Courses